NeoGenomics Inc

Financials

Fluxo de caixa operacional 9.8 M-25.33 M20.33 M8.88 M1.34 M 5.23 M Fluxo de caixa de investimento -5.47 M3.56 M-9.31 M-277 K-6.3 M -12.34 M Fluxo de caixa de financiamento 687 K949 K-202.43 M765 K431 K -200.29 M Fluxo de caixa livre -1.8 M-29.83 M14.01 M570 K-6.53 M -21.78 M

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

NEO

Financials

NeoGenomics Inc

Notícias

Neo Performance no 4º tri de 2025: crescimento do EBITDA apesar de LPA abaixo do esperado

Neo Performance erra previsão de LPA no 4º tri de 2025

William Blair mantém classificação Market Perform para Neogenomics após decisão de cobertura do Medicare

William Blair reiterates Market Perform on Neogenomics stock after Medicare coverage decision

Ações da Neogenomics recebem cobertura do Medicare para teste baseado em sangue

Neogenomics stock gets Medicare coverage for blood-based test

Ações da Neogenomics recebem reembolso MolDX para teste de câncer

Neogenomics stock gets MolDX reimbursement for cancer test

Teste PanTracer LBx da NeoGenomics recebe cobertura do Medicare

NeoGenomics’ PanTracer LBx test receives Medicare coverage

NeoGenomics na Conferência Leerink: foco em crescimento estratégico

NeoGenomics at Leerink Conference: Strategic Growth Focus